Optigenex (Optigenex) Debt-to-Equity : -1.11 (As of Jun. 2008)

View and export this data going back to 2004. Start your Free Trial

What is Optigenex Debt-to-Equity?

Optigenex's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2008 was $8.18 Mil. Optigenex's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2008 was $3.24 Mil. Optigenex's Total Stockholders Equity for the quarter that ended in Jun. 2008 was $-10.28 Mil. Optigenex's debt to equity for the quarter that ended in Jun. 2008 was -1.11.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Optigenex's Debt-to-Equity or its related term are showing as below:

OPGX's Debt-to-Equity is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 0.23
* Ranked among companies with meaningful Debt-to-Equity only.

Optigenex Debt-to-Equity Historical Data

The historical data trend for Optigenex's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optigenex Debt-to-Equity Chart

Optigenex Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Debt-to-Equity

1.47

-1.27

-1.16

Optigenex Quarterly Data
	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08
Debt-to-Equity	Get a 7-Day Free Trial											-1.08	-1.19	-1.16	-1.09	-1.11

Competitive Comparison of Optigenex's Debt-to-Equity

For the Diagnostics & Research subindustry, Optigenex's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optigenex's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optigenex's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Optigenex's Debt-to-Equity falls into.

Optigenex Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Optigenex's Debt to Equity Ratio for the fiscal year that ended in Dec. 2007 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.514	+	4.427)	/	-7.682
	=	-1.16

Optigenex's Debt to Equity Ratio for the quarter that ended in Jun. 2008 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.182	+	3.243)	/	-10.276
	=	-1.11

Optigenex (OTCPK:OPGX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Optigenex Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Optigenex's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Optigenex (Optigenex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optigenex Inc (OTCPK:OPGX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Sam Rayburn Highway, Melissa, TX, USA, 75454

Website

http://www.optigenex.com

Optigenex Inc is an applied sciences company dedicated to solutions for healthy age management. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging.

Executives

Richard S Serbin

director, 10 percent owner, officer: CEO, President & Secretary

750 LEXINGTON AVENUE, 6TH FLOOR, NEW YORK NY 10022

Optigenex (Optigenex) Headlines

No Headlines